NB compounds are potent and efficacious FOXM1 inhibitors in high-grade serous ovarian cancer cellsCassie Liu(Stony Brook University Hospital), Adam R. Karpf(University of Nebraska Medical Center)Journal of Ovarian ResearchMay 4, 202410.1186/s13048-024-01421-4Cited by 10SaveCiteExport RISWatch citationsRelated PapersPan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer|Cancers|2019|226New 1,1-diarylethylene FOXM1 inhibitors potently reduce intracellular FOXM1 and suppress high-grade serous ovarian carcinoma cell viability|Research Square|2022|2